- House Republicans subpoenaed eight health insurers regarding $27 billion in improper annual ACA payments.
- Investigators are targeting broker commissions and ghost enrollment to identify potential fraud within the subsidy system.
- The probe coincides with the expiration of enhanced credits, potentially raising premiums for 22 million Americans.
Section 1: Overview: House Judiciary Committee subpoenas over ACA tax credits
House Judiciary Committee Republicans, led by Chair Jim Jordan, issued subpoenas on February 9, 2026, to eight health insurers over concerns tied to ACA premium tax credits. The investigation lands at a tense moment for households that rely on subsidies to reduce monthly premiums. It also arrives as Congress debates whether, and how, to rebuild guardrails around the subsidy system.
GAO findings sit at the center of the dispute. Federal auditors have estimated $21 billion in unreconciled credits and $27 billion in annual improper payments connected to ACA premium tax credits. Those figures do not prove intentional wrongdoing by any one company. Still, they frame why lawmakers want enrollment, payment, and broker-commission data that insurers hold at scale.
Table 2: Key financial figures (context)
| Category | Amount | Notes |
|---|---|---|
| Unreconciled ACA premium tax credits | $21 billion | GAO estimate of credits not reconciled |
| Annual improper payments | $27 billion | GAO estimate tied to improper payments |
Section 2: Insurers subpoenaed and deadlines
Eight insurers were named in the subpoenas, with records due by February 23, 2026. Each plays a major role in ACA marketplaces, either nationally or in large regional footprints. The compressed turnaround increases pressure on compliance teams and raises the stakes for how Congress interprets any gaps.
Table 1: Targeted insurers and deadlines
| Insurer | Status/Relation to Subpoena | Document Deadline |
|---|---|---|
| Centene Corporation | Subpoena recipient | February 23, 2026 |
| CVS Health (Aetna) | Subpoena recipient | February 23, 2026 |
| Elevance Health | Subpoena recipient | February 23, 2026 |
| GuideWell Mutual Holding Corporation (Florida Blue) | Subpoena recipient | February 23, 2026 |
| Oscar Health | Subpoena recipient | February 23, 2026 |
| Kaiser Permanente | Subpoena recipient | February 23, 2026 |
| Health Care Service Corporation | Subpoena recipient | February 23, 2026 |
| Blue Shield of California | Subpoena recipient | February 23, 2026 |
Section 3: Subpoena demands: what information is requested
The subpoenas seek concrete market-wide information, not insurer balance sheets. That choice matters. It suggests the House Judiciary Committee is hunting for patterns across enrollment and subsidy flows, and for points where fraud controls may be weak.
Four requests stand out:
- Number of ACA enrollees receiving subsidies (2020–2025) and the total subsidy amounts received over that period. That timeframe captures the later pandemic-era enrollment surge and the period when subsidies were expanded.
- Enrollees who received subsidies but did not use benefits in a given year. Non-use is not automatically suspicious. Some people have a healthy year. Yet persistent non-use, paired with irregular identity signals, can be a red flag for “ghost” enrollment.
- Compensation paid to brokers and agents tied to ACA marketplace business. Lawmakers have argued that commission structures can create incentives for rapid sign-ups, including for people who may not be eligible.
- Supporting documentation that clarifies how insurers track, validate, and report these metrics across internal systems and marketplace feeds.
Read together, the list points to a classic oversight question: where does the subsidy process rely on self-attestation and intermediaries, and where do insurers have tools to detect anomalies early.
Section 4: Context: prior actions and audit findings
December 2025 set the stage. Before issuing subpoenas, the committee sent voluntary document requests to insurers. Companies responded, but Jim Jordan later said the material was insufficient. Subpoenas often follow that kind of standoff. Voluntary cooperation becomes a test, and lawmakers escalate when responses feel incomplete or too aggregated to be useful.
Audit work added urgency. Federal auditors flagged subsidized coverage for nearly two dozen nonexistent individuals. That detail is small in raw count, yet politically potent. It supports the view that identity controls can fail, and that subsidy dollars can follow bad data.
Two competing interpretations have driven the debate since then. One side argues the scale of GAO’s numbers implies structural vulnerabilities that demand tighter eligibility checks and sharper broker oversight. The other side warns that chasing fraud narratives can lead to policy changes that push eligible families out of coverage through paperwork hurdles. Both claims can be true in part. A program can have real fraud risks and still serve millions who qualify.
Section 5: Policy backdrop: expiration of enhanced ACA premium tax credits
January 1, 2026 marked a major break. Enhanced ACA premium tax credits expired on that date, after expansions tied to the American Rescue Plan Act (2021) and Inflation Reduction Act (2022) ended. The timing matters because subsidy policy and fraud oversight are now being debated at the same time, with households exposed to immediate cost swings.
Analysts have projected that premiums could rise for 22 million enrollees by an average of $1,016 per person, described as a 114% increase. That type of jump, if it hits as modeled, can reshape enrollment quickly. Some people may downgrade coverage. Others may drop coverage altogether.
Subsidy funding projections also frame the politics. Estimates cited in the debate include subsidy reductions of $23 billion in 2026, $32 billion in 2027, and $335 billion over 10 years.
[warning] ⚠️ Enhanced ACA premium tax credits expired on January 1, 2026; potential premium increases and subsidy reductions are central to ongoing policy debates
Table 2: Key financial figures (policy backdrop)
| Category | Amount | Notes |
|---|---|---|
| Potential premium impact | 22 million | Enrollees projected to face changes |
| Average premium increase | $1,016 | Average increase per person cited in projections |
| Subsidy reduction (2026) | $23 billion | Estimated reduction in subsidy support |
| Subsidy reduction (2027) | $32 billion | Estimated reduction the following year |
| Subsidy reduction (10 years) | $335 billion | Estimated cumulative reduction |
| ACA tax credits cost (2024) | $122 billion | Cited cost figure tied to earlier changes |
| Projected savings (10 years) | $211 billion | Cited savings figure tied to earlier changes |
Section 6: Related legislative developments
Several proposals now compete to define the next phase of ACA tax credits and the compliance rules around them.
One route is a targeted extension with offsets and tighter rules. The Fix It Act (introduced November 10, 2025) by Reps. Sam Liccardo and Kevin Kiley would provide a two-year extension of enhanced credits. The bill pairs that extension with Medicare Advantage cuts, eligibility caps, and provisions aimed at curbing broker fraud. Supporters argue it strikes a balance: temporary relief for premium shock, plus cleaner enrollment practices. Critics may argue that offsets and caps can shift costs elsewhere, or that enforcement tools can create friction for lawful enrollees.
Another route is replacement. Sen. Rick Scott has promoted Trump Health Freedom Accounts, described as HSA-like funds that would replace credits. Sen. Bill Cassidy has proposed allowing HSA contributions for bronze plans. Both concepts reflect a Republican preference for account-based support rather than income-based premium tax credits. Backers say accounts give consumers more control. Opponents counter that fixed contributions may not track premium growth, especially in high-cost areas.
A third marker is already law. The One Big Beautiful Bill Act, signed July 4, 2025, trimmed ACA tax credits. It was described as costing $122 billion in 2024 while producing $211 billion in savings over 10 years. Those numbers highlight a recurring tension: credits can be expensive in the short term, while budget scoring can reward longer-term reductions.
Section 7: Stakeholder perspectives and next steps
Follow-up letters to insurers have made the committee’s intent plain. The document production is meant to inform “legislative fixes” aimed at ACA fraud and improper payments. That frames the subpoenas as more than a one-off compliance fight. It is part of a campaign to rewrite rules around eligibility verification, broker conduct, and reconciliation.
Industry leaders have pushed back on the implication that insurers drive premium hikes. AHIP CEO Mike Tuffin has argued that premium rises reflect medical costs, not insurer actions. That claim fits standard rate-setting mechanics, where hospitals, physician services, drugs, and utilization trends often dominate premium growth. Yet lawmakers can respond that even if medical costs drive premiums, insurers still influence enrollment integrity through broker relationships, data checks, and reporting.
Two tracks now run in parallel. One is oversight, built around subpoenas and the February 23, 2026 deadline. The other is legislation, where the Fix It Act, Trump Health Freedom Accounts, and HSA-related proposals compete with approaches that keep ACA premium tax credits but tighten controls.
[action] ✅ Readers should watch for congressional updates on ACA fraud reforms and insurer document submissions by February 23, 2026
This article discusses ongoing legislative and regulatory matters affecting health policy and subsidies; readers should consult official government sources for the latest amendments and deadlines.
Tax and legal implications can vary by individual circumstances; this piece provides context based on current public findings and proposed reforms.
